Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Idarucizumab for Reversal of Dabigatran-Associated Anticoagulation.
Mechanism and regulation of class switch recombination.
Postpartum Hemorrhage
Rubella
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Idarucizumab for Reversal of Dabigatran-Associated Anticoagulation.
Yogaratnam D, Ditch K, Medeiros K, Doyno C, Fong JJ. Idarucizumab for Reversal of Dabigatran-Associated Anticoagulation. Ann Pharmacother. 2016 10; 50(10):847-54.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Antithrombins
Blood Coagulation
Clinical Trials as Topic
Dabigatran
Hemorrhage
Humans
Treatment Outcome
authors with profiles
Jeffrey J Fong PharmD
Dinesh Yogaratnam PharmD